Purchase Order HHSN273201700045P
- Not listed
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Environmental Health Sciences awarded a $33,012.50 firm fixed-price purchase order to Qiagen, LLC, a division of Qiagen N.V. This contract is for CLC BIO SOFTWARE FY24, with a completion date of December 31, 2024. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academic research. The company has a history of...
- The National Institute of Environmental Health Sciences (NIEHS) awarded a $32,550.00 firm fixed-price purchase order contract to Qiagen, LLC for CLC BIO SOFTWARE FY25. This contract is not associated with a set-aside designation. Qiagen, LLC is a division of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics. Qiagen has provided a range of products and services to federal agencies in the past, including...
- This is a $85,445 firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of Qiagen N.V., for CLC Genomics Workbench and CLC Genomics Server software licenses, modules, and maintenance services. The purchase supports the genomic analysis capabilities of the NIH Clinical Center's Department of Laboratory Medicine in its clinical research and testing programs. The award is not associated with a larger contract vehicle and does...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center awarded a $17,600.00 firm fixed price purchase order to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The contract is for the renewal of a data analysis software license and has a completion date of March 30, 2025. Qiagen is a provider of sample and assay technologies that supports federal agencies' biomedical research, public health, law enforcement, and...
- This is a federal purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and laboratory equipment. The $38,852.70 firm fixed-price contract is for the provision of CLC SOFTWARE SOFTWARE in fiscal year 2023, with a completion date of January 31, 2024. The contract does not have a set-aside designation. Qiagen, LLC is a subsidiary of the multinational...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS) to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and genomic analysis products. The $389,994.64 contract, which does not have a set-aside designation, is for the delivery of various scientific equipment and consumables to support NIEHS's biomedical research and public health initiatives. Key items included under the contract are DNA/RNA...
- The National Institute of Environmental Health Sciences (NIEHS), under the Department of Health and Human Services, awarded a $32,550 firm fixed-price purchase order to Qiagen, LLC for CLC Workbench Network Maintenance. The contract, effective January 1, 2026, with an ultimate completion date of December 31, 2026, supports NIEHS's research operations at Research Triangle Park, North Carolina. This award represents a sole-source procurement conducted under 41 U.S.C. Section 1901, reflecting the...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the U.S. Department of Health and Human Services. The contract was awarded to Qiagen, LLC, a division of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharmaceuticals, and academia. The contract has a ceiling value of $142,272.00 and a performance period ending on December...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract, valued at $15,641.00, is for the provision of genomic research and analysis tools, including DNA/RNA extraction kits, next-generation sequencing, digital PCR systems, sample preparation equipment, and bioinformatics software....
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Qiagen, LLC for a maintenance agreement valued at $13,967.00. The contract has an ultimate completion date of August 31, 2025. Qiagen, LLC is a division of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics. Qiagen has provided a range of...
This is a $127,198.84 firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the Department of Health and Human Services, to Qiagen, LLC for the renewal of CLC bio licenses and maintenance. The contract has an ultimate completion date of January 31, 2021 and was awarded on January 4, 2017. Qiagen, LLC is a division of the international provider of sample and assay technologies Qiagen N.V. and has provided various products and services, including DNA/RNA extraction kits, next-generation sequencing, and bioinformatics software, to federal agencies such as the Department of Health and Human Services, Department of Veterans Affairs, and Department of Defense. This contract award is not associated with a larger contract vehicle and does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Funding Only Action | ($1) | 4/2/25 | |
| P00003 | Exercise an Option | $35.2k | 12/17/19 | |
| P00002 | Exercise an Option | $32.8k | 12/18/18 | |
| 1 | Exercise an Option | $30.6k | 11/30/17 | |
| Not listed | Not listed | $28.6k | 1/4/17 |